Literature DB >> 15977456

Failure to treat osteoporosis and the risk of subsequent fractures in elderly patients with previous hip fracture: a five-year retrospective study.

Francesc Formiga1, Agnes Rivera, Juan Miquel Nolla, Antonio Coscujuela, Ana Sole, Ramón Pujol.   

Abstract

BACKGROUND AND AIMS: Considering the results of cost-effective analyses, the National Osteoporosis Foundation recommends osteoporosis treatment for patients with previous hip fracture. The aim of this study was to examine the application of adequate treatment for osteoporosis among patients who have had a hip fracture. We also evaluated the rate of subsequent fractures after five years.
METHODS: We conducted a retrospective data study, with a follow-up at five years after discharge, in a tertiary teaching hospital with orthopedic services and all medical specialities. Treatment for osteoporosis and subsequent fracture rates were evaluated in 114 patients with hip fracture. Functional status was assessed using the Barthel Index (BI). We also evaluated the rate of subsequent fractures after five years.
RESULTS: Twenty-five patients (22%) had a new fracture at some moment during the follow-up. Six percent at discharge and 12% at five years of follow-up were receiving adequate treatment for osteoporosis. After five years of follow-up, a decline in their BI persisted in 72% of the 43 surviving patients.
CONCLUSIONS: Few patients were receiving adequate treatment for osteoporosis after hip fracture. Their fracture rates and functional decline were important.

Entities:  

Mesh:

Year:  2005        PMID: 15977456     DOI: 10.1007/BF03324580

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  9 in total

Review 1.  Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study.

Authors:  T Nymark; J M Lauritsen; O Ovesen; N D Röck; B Jeune
Journal:  Osteoporos Int       Date:  2006-07-06       Impact factor: 4.507

2.  Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.

Authors:  F Cosman; J H Krege; A C Looker; J T Schousboe; B Fan; N Sarafrazi Isfahani; J A Shepherd; K D Krohn; P Steiger; K E Wilson; H K Genant
Journal:  Osteoporos Int       Date:  2017-02-07       Impact factor: 4.507

3.  Incidence of second hip fracture and compliant use of bisphosphonate.

Authors:  Y-K Lee; Y-C Ha; B-H Yoon; K-H Koo
Journal:  Osteoporos Int       Date:  2012-12-18       Impact factor: 4.507

4.  Bisphosphonate use and subsequent hip fracture in South Korea.

Authors:  Y-K Lee; Y-C Ha; H J Choi; S Jang; C Park; Y-T Lim; C S Shin
Journal:  Osteoporos Int       Date:  2013-05-17       Impact factor: 4.507

5.  Falls in nonagenarians living in their own homes: the Nonasantfeliu study.

Authors:  F Formiga; A Ferrer; E Duaso; C Olmedo; R Pujol
Journal:  J Nutr Health Aging       Date:  2008-04       Impact factor: 4.075

6.  Which patients are at risk for not receiving anti-osteoporosis treatment following hip fracture?: An ACS NSQIP analysis.

Authors:  Adam M Gordon; Azeem Tariq Malik; Safdar N Khan
Journal:  J Clin Orthop Trauma       Date:  2021-03-20

7.  A retrospective analysis of bilateral fractures over sixteen years: localisation and variation in treatment of second hip fractures.

Authors:  Laura M Kok; Tim J van der Steenhoven; Rob G H H Nelissen
Journal:  Int Orthop       Date:  2010-12-17       Impact factor: 3.075

8.  Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.

Authors:  C Klop; D Gibson-Smith; P J M Elders; P M J Welsing; H G M Leufkens; N C Harvey; J W J Bijlsma; T-P van Staa; F de Vries
Journal:  Osteoporos Int       Date:  2015-05-12       Impact factor: 4.507

9.  Identifying Unmet Treatment Needs for Patients With Osteoporotic Fracture: Feasibility Study for an Electronic Clinical Surveillance System.

Authors:  Fong-Ci Lin; Chen-Yu Wang; Rung Ji Shang; Fei-Yuan Hsiao; Mei-Shu Lin; Kuan-Yu Hung; Jui Wang; Zhen-Fang Lin; Feipei Lai; Li-Jiuan Shen; Chih-Fen Huang
Journal:  J Med Internet Res       Date:  2018-04-24       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.